Siriuspoint SEC Filings

SiriusPoint Ltd. announced that its wholly owned subsidiary International Medical Group (IMG) has signed a definitive agreement to acquire the World Nomads travel insurance business from nib Group. World Nomads generates approximately $40 million of gross written premium and is a global travel insurance and lifestyle brand.

The deal is expected to significantly expand IMG’s travel insurance distribution, adding a broad base of independent, lifestyle, and adventure travelers and extending its reach to Australia, Brazil, and Canada. Together with IMG’s recent acquisition of Assist America, which produces around $20 million in annual assistance revenues, the combination creates an integrated travel insurance and assistance platform.

The company states that both the World Nomads and Assist America acquisitions are accretive to return on equity and earnings per share. An initial closing for the majority of World Nomads is targeted for the second or third quarter of 2026, with final closing in the second half of 2027, in each case subject to regulatory approvals and other customary conditions.

Donald Smith & Co., Inc., a Delaware investment adviser, filed a Schedule 13G reporting beneficial ownership of 8,428,966 SiriusPoint Ltd common shares, representing about 7.2% of the class. The firm has sole voting power over most of these shares and holds them for advisory clients.

The filing states the securities were acquired and are held in the ordinary course of business, not to change or influence control of SiriusPoint. No single underlying client or other person is reported to own more than five percent of SiriusPoint’s outstanding common stock.

SiriusPoint Ltd. reports that a subsidiary has completed the previously announced sale of its entire equity stake in Arcadian Holdings Limited to Comet Bidco Limited, an acquisition vehicle of funds affiliated with Lee Equity Partners. Under the Share Purchase Agreement dated October 3, 2025, SiriusPoint Bermuda Insurance Company Ltd., as seller, received cash consideration of $140 million, subject to customary post-closing adjustments. The transaction closed after all customary closing conditions were met, including required regulatory approvals.

SiriusPoint Ltd. has announced the full redemption of all 8,000,000 of its 8.00% Resettable Fixed Rate Preferred Shares, Series B. The redemption will occur on February 26, 2026, retiring this entire preferred share series.

The company also stated its intent to delist and deregister the Series B Preference Shares from the New York Stock Exchange and under U.S. securities laws. These steps consolidate its capital structure by removing this listed preferred security from public trading.

SiriusPoint Ltd’s chief executive officer and director Scott Egan reported an internal transfer of 545,083 common shares of SiriusPoint on 12/19/2025. The shares moved from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, and the filing states that no consideration was paid for the transfer.

After the transactions, Egan directly owns 239,083 common shares, and indirectly owns 545,083 common shares through Egan Family Investment Ltd. The filing notes that these holdings include restricted shares.

A shareholder of the SPNT issuer has filed a Rule 144 notice to sell 37,311 shares of common stock. The sale is planned to occur around 12/12/2025 on the NYSE through J.P. Morgan Securities LLC. Based on the filing, the aggregate market value of the shares to be sold is $831,289.08, compared with 116,814,640 shares of the same class outstanding. The shares were originally acquired on 12/31/2012 as a gift from Clare Loeb, who had acquired the shares earlier. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.

SiriusPoint Ltd. reported an insider equity transaction by its Group Chief Underwriting Officer, Anthony Shapella. On 11/30/2025, 2,375 common shares were withheld with a transaction code "F," which indicates shares were surrendered to cover current tax liabilities related to the vesting of restricted shares. The price is shown as $0 because this is a tax withholding event rather than an open-market sale or purchase.

After this transaction, Shapella beneficially owned 42,215 common shares, which the disclosure notes include restricted shares. This type of activity is administrative in nature and reflects routine handling of taxes when equity awards vest.

Donald Smith & Co., Inc. filed a Schedule 13G reporting a passive stake in SiriusPoint Ltd (SPNT). The filer reports 7,402,682 shares beneficially owned, representing 6.34% of the common stock as of the event date 09/30/2025.

The filing lists sole voting power over 7,135,119 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P., and sole dispositive power over 7,339,609 shares for Donald Smith & Co., Inc. and 63,073 shares for DSCO Value Fund, L.P. The certification states the securities were acquired and are held in the ordinary course and not to change or influence control.